# Toripalimab Based Induction Chemotherapy Followed by De-escalation Protocols in HPV-related OPSCC

> **NCT04867330** · NA · UNKNOWN · sponsor: **Fudan University** · enrollment: 46 (estimated)

## Conditions studied

- Oropharyngeal Carcinoma
- Immune Checkpoint Inhibitor
- De-escalation

## Interventions

- **OTHER:** Toxicities reduced treatment arm

## Key facts

- **NCT ID:** NCT04867330
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-02-01
- **Primary completion:** 2021-05
- **Final completion:** 2026-01
- **Target enrollment:** 46 (ESTIMATED)
- **Last updated:** 2021-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04867330

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04867330, "Toripalimab Based Induction Chemotherapy Followed by De-escalation Protocols in HPV-related OPSCC". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04867330. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*